Gaucher Disease: Progressive Mesenteric and Mediastinal Lymphadenopathy Despite Enzyme Therapy

Journal of Pediatrics

Volumn 150, Issue 2, 2007, Pages 202-206

  Burrow, T Andrew ^a   Cohen, Mitchell B ^a   Bokulic, Ronald ^a   Deutsch, Gail ^a   Choudhary, Arabinda ^a   Falcone Jr , Richard A ^a   Grabowski, Gregory A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIGLUCERASE; METRONIDAZOLE; PENICILLIN G; TRIACYLGLYCEROL;

ARTICLE; CASE REPORT; CYTOMEGALOVIRUS INFECTION; DIET THERAPY; ENZYME REPLACEMENT; ENZYME THERAPY; EPSTEIN BARR VIRUS; GAUCHER DISEASE; HUMAN; HUMAN TISSUE; LYMPHADENOPATHY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN LOSING GASTROENTEROPATHY; VIRUS INFECTION;

CHILD, PRESCHOOL; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HEPATOMEGALY; HUMANS; LYMPHATIC DISEASES; MAGNETIC RESONANCE IMAGING; MALE; MESENTERY; RISK ASSESSMENT; SPLENOMEGALY; TIME FACTORS;

EID: 33846362207     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2006.10.062     Document Type: Article

References (8)

1. Beutler E., and Grabowski G.A. Gaucher Disease. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Diseases. 8th ed (2001), McGraw-Hill, New York 3635-3668
2. Weinreb N.J., Charrow J., Andersson H.C., Kaplan P., Kolodny E.H., Mistry P., et al. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. Am J Med 113 (2002) 112-119
3. Zhao H., Bailey L.A., Elsas II L.J., Grinzaid K.A., and Grabowski G.A. Gaucher disease: in vivo evidence for allele dose leading to neuronopathic and nonneuronopathic phenotypes. Am J Med Genet A 116 (2003) 52-56
4. Muntean W., and Rossipal E. Loss of inhibitors of the blood coagulation system in protein-losing enteropathy. [author's transl]. Klin Padiatr 191 (1979) 20-23
5. Altarescu G., Hill S., Wiggs E., Jeffries N., Kreps C., Parker C.C., et al. The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease. J Pediatr 138 (2001) 539-547
6. Grabowski G.A., Leslie N., and Wenstrup R. Enzyme therapy for Gaucher disease: the first 5 years. Blood Rev 12 (1998) 115-133
7. Lim A.K., Vellodi A., and McHugh K. Mesenteric mass in a young girl-an unusual site for Gaucher's disease. Pediatr Radiol 32 (2002) 674-676
8. Cox T., Lachmann R., Hollak C., Aerts J., van Weely S., Hrebicek M., et al. Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet 355 (2000) 1481-1485